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Abstract
Neuropathologically, Alzheimer's disease (AD) is characterized by neuritic
plaques and neurofibrillary tangles. Evidence has suggested that a protein called
B-amyloid (BA) is a major component of the neuritic plaques and may playa role
in the neurodegeneration seen in AD.

The cellular mechanisms by which BA

induces neurotoxicity, however, are still unclear. Recent evidence suggests that the
aggregational state of BA may be relevant to its neurotoxicity. Whether portions
of the BA protein or the entire sequence produces neurotoxicity in neurons,
however, remains a controversy. Still another controversy is whether BA is directly
neurotoxic to neurons or whether it increases the vulnerability of neurons. Recent
evidence reported by Doman, Kang, McCampbell and Kang, that injections of
BA(25-35) with a low dose of ibotenic acid into the hippocampus did disrupt the

acquisition of spatial learning in the rat, supports the vulnerability hypothesis. They
suggest that the synergistic effect between BA and ibotenic acid may have produced
the neurotoxic effect. In light of recent evidence (McCampbell, Peterson and
Tinkler, unpublished) that injections of BA(1-42) alone did not disrupt the retention
of a spatial learning task, in this study we assessed the increased vulnerability
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hypothesis by co-injecting fiA(1-42) with a subthreshold dose of ibotenic acid into
the hippocampus of male rats. Another problem related to fiA's neurotoxicity may
concern the extent of hippocampal damage it produces. Therefore, we assessed the
effects of multiple injections of fiA(1-42) and ibotenic acid into the hippocampus of
male rats.

Although preliminary, the results of this study conclude that co

injections of fiA(1-42) and ibotenic acid do not disrupt the retention of a spatial
learning task.
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Alzheimer's Disease (AD) was first described by psychiatrist, Alois
Alzheimer, in 1907 (9). Today, AD is the most common of the neurodegenerative
diseases of aging (9). In the aging population of the world, AD represents a major
health problem for which there is at present no effective treatment.
Epidemiologic.al studies report that currently there are over 4 million people
suffering from AD in the United States.alone. James Goldman and Luden Cote (8)
estimate that AD accounts for about 70% of all age related cases of dementia. It
afflicts an estimat~d 5-11 % of the population over 65 and more than 47 % over the
age of 85 (8).
Alzheimer's disease is clinically characterized by progressive impairments in
memory, language, visuo-spatial skills and behavior (5).

Typically, the

neuropathology of AD is characterized by extracellular neuritic plaques and
intracellular neurofibrillary tangles (13,19,17).

Although a certain amount of

neuritic plaques and neurofibrillary tangles can be found in normal aged people,
they are not as dense or severe as seen in victims of AD. The cerebral cortex and
hippocampus appear to be selectively targeted and are the primary sites of this
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neuropathology.
Recently, several studies have reported that a 39-42 amino acid long peptide,
called B-amyloid (BA) is a major component of the neuritic plaques and may play
a role in the neuronal degeneration of AD. This peptide is called BA because of
its partial B-pleated structure (5).
The amyloid peptide is derived from a larger amyloid transmembrane
glycoprotein precursor (BAPP) that exists in several forms (15,18,25,32). Two
forms contain Kunitz-type protease inhibitor (Kpn while two forms lack this
domain. Mature BAPP consists of a long N-terminal (which lies outside the cell),
a transmembrane portion (a segment that spans the membrane) and an intracellular
C-terminal portion. The BA peptide resides in the transmembrane portion of the
peptide (part of it lies within the membrane and part of it lies in the extracellular
portion of the membrane).
The BAPP gene is localized to chromosome 21 (27). Interestingly, Down's
syndrome patients also have mutations of chromosome 21 and develop amyloid
pathology (27).

These findings have created increasing. interest in the role of

amyloid in the pathology of AD.
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To date two different enzymatic processing pathways of BAPP have been
described. They are a and B secretasepathways (18). If enzymatic cleavage occurs
along the a-secretase pathway the protein is cleaved within the BA fragment
(preventing the formation of intact BA) and normal secreted BAPP (APP:J results.
APP. can contain several functional domains including the KPI region, which is

described as b.eing a serine protease inhibitor. This suggests that a normal function
of secreted BAPP could be the regulation of protease activity. Other functional
domains may stimulate cell proliferation, or regulate Ca2+ and neuroprotection.
The fact that the intact BA fragment is generated and deposited in the brains
of healthy aged humans, has encouraged researchers to investigate an alternative
processing route that leaves the BA region intact. In this second secretory pathway,
involving B-secretase, BAPP is cleaved at the amino terminus (beginning) of the BA
sequence

~18).

This means that intact BA is released into the extracellular fluid.

The implication of these two pathways (a and B-secretase) is that not only
does APPs have normal functions in healthy brains but the BA fragment is also
generated in healthy humans. Therefore, high levels of BA in the cerebral spinal
fluid (CSF) is not a straightforward indicator of AD. Realizing, however that the
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alternative proteolytic pathway (B-secretase) is markedly increased in AD, it may
serve as a risk factor in the development of the disease.
Whether BA is directly neurotoxic, or produces neurotoxicity via an indirect
mechanism , however, remains somewhat controversial.

For example, BA

fragments have been reported to be neurotoxic to hippocampal neurons in vitro (in
cell

culture)(~,14,24).

Accumulating evidence suggests that BA's neurotoxic

properties are presumably localized to amino acid residues 25-35 (12,26). As a
result, it has been suggested that the accumulation of extracellular amyloid deposits
may play a role in the neuronal degeneration that occurs in AD.
Studies that have examined the effects of BA in vivo (in live animals) have
resulted in apparent contradictions. Some studies, in vivo, have reported direct
neurotoxicity of BA (11,17). For example, Kowall, Beal, Busciglio, Duffy and
Yankner (1991) recently reported that intracerebral unilateral injections of20 fmol
of BA(1-40) into the hippocampus of the adult rat brains caused a significant
neuronal degeneration in the CAl layer of the hippocampus 0.5 - 1.0mm from the
injection site. Other studies, however, report that BA is not directly neurotoxic in
vivo (1,28,23). Stein-Behrens, Adams, Yen and Sapolsky recently reported that
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injections of BA(25-35) in the hippocampus showed no evidence of neurotoxicity
in the neurons (28).
One possible explanation for these conflicting reports may be related to the
self-aggregational properties of BA. Recently Cottman, Pike and Copani suggested
that some of the discrepancies in the experiments may be due to the aggregational
state of .BA (4). .BA peptide can exist in both soluble and insoluble forms, but
toxicity appears to reside in insoluble aggregates, whereas soluble .BA may have
little direct neurotoxicity. Cottman reports that BA protein (in vivo) exists primarily
in an insoluble aggregated state within neuritic plaques. It has the property of
spontaneous self-assembly into large, insoluble aggregates. Cottman also reported
that in vitro only aggregated BA is associated with toxicity in developing
hippocampus cultures. These findings suggest that in experiments done in vivo BA
may be aggregating inside the injection needle, never entering the animals system.
This may explain why some in vivo studies report that .BA is not neurotoxic to
neurons. If .BA, therefore, is contributing to the progressive neurodegeneration of
AD, the aggregated state of the protein may very well be relevant to its
neurotoxicity.
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The sequence of J3A (either portions of the peptide or the entire sequence)
that produces neurotoxicity in neurons, however, is yet to be elucidated. Several
studies have reported that the neurotoxic properties of J3A are localized to the amino
acid residues 25-35 or 1-40 (7,12,26,29,31). In light of recent evidence suggesting
that the soluble and insoluble states of J3A may playa role in its toxicity, a newly
purified portion of the peptide (Abbott Laboratories, Abbott Park, Illinois)
consisting of residues 1-42 has been under investigation. Presumably, J3A(1-42)
has more hydrophobic regions on the peptide, making it more insoluble. It is
readily dissolved in dimethylsulfoxide (DMSO). Intriguingly, this may solve some
of the controversies described earlier with in vivo studies. If the aggregation of
J3A can be prevented until the solution enters the animal's tissue, by dissolving the
peptide in DMSO it will have an increased chance of exiting the needle. Recent in

vitro studies also report that aggregated J3A(1-42) is neurotoxic to immature rat
hippocampal neurons (21,22). For this reason, the present study used J3A(1-42)
to examine the effects of the amyloid peptide.
Currently, little is known about the behavioral effects that J3A injections may
produce. Some investigators, however, have demonstrated that while J3A was not,
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by itself neurotoxic to neurons in rats, mouse and human cortical neurons, it
indirectly caused neurotoxicity.. According to these studies, fiA is rendering
neurons more vulnerable to. outside insults such as excitotoxins or to glucose
deprivation (3,6,10,16). For example, Dornan, Kang, McCambell and Kang (6)
reported that bilateral injections of fiA(25-35) injections did not produce
neurotoxicity in rat hippocampal neurons. Co-injections of fiA(25-35) with a
subthreshold dose of ibotenic acid (an excitotoxin that causes Ca2+ influx),
however, did produce lesions along with focal deposits in the hippocampus of rats.
This fiA/ibotenic acid injection also disrupted the acquisition of spatial learning in
the rat.

This strongly suggests that fiA is exerting its neurotoxic effects not

directly, but indirectly via an unknown mechanism. In that study, Dornan et al.
suggest that the neurotoxic effect on hippocampal neurons and the subsequent
disruption . . of the acquisition of spatial learning was a result of the increased
vulnerability of neurons.

They further suggest that the neurotoxicity may be

produced by the synergistic effect of fiA(25-35) with ibotenic acid.
In light of the above findings and recent evidence reported at the 5th annual

Illinois Wesleyan Student Research Conference, that bilateral injections of fiA(1
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42) alone does not produce a disruption of the retention of a spatial learning task,
in the present study we further assessed the increased vulnerability hypothesis by
co-injecting fiA(l-42) with a subthreshold dose of ibotenic acid into the
hippocampus of male rats.
Another problem related to 13A's neurotoxicity may concern the extent of
hippocampal oamage it produces. Therefore, in this study we also assessed the
effects of multiple injections of fiA(I-42) and ibotenic acid into the hippocampus of
male rats.
Method
Animals and Groups
A total of 29 male Long Evans rats were used in this study. They were
housed individually on a 12L:12D cycle and maintained at 80-85 % of free body
weight. They had free access to water except during behavioral testing.
All animals were pre-tested on a partially baited 8-arm radial arm maze until
the criterion of eating for at least three consecutive sessions was met. Seven animals
did not meet this criterion and were not used in the study. Immediately following
the screening test the remaining animals were randomly placed into three groups
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for surgery. Each animal was anesthetized with sodium pentobarbital (40mg/kg)
and received four bilateral injections throughout the hippocampus.

A peptide

corresponding to the first 42 amino acids of BA [BA(1-42)] was synthesized,
purified and dissolved in dimethylsulfoxide (DMSO). This vehicle was used in
all control injections as well. The following injections were administered in a 1 J,LL
volume via a 1 J,LL Hamilton syringe: Group 1, BA(1-42) 7 nmol/injection per side

+ 4 nmol/injection per side of ibotenic' acid (mO); Group 2, scrambled BA peptide
7 nmol/injection per side

+

4 nmol/injection per side of mo; Group 3, rno 4

nmol/injection pet side. In order to prevent back flow and minimize tissue damage,
the injection took place over approximately 3 minutes and the syringe was left in
place after the injection for another 3 minutes.
Surgery
After the animals were anesthetized, they were placed into a stereotaxic
apparatus. A stereotaxic apparatus is a device containing a holder that fixes the
animal's head in a standard position and a carrier that moves a cannula (hollow
tube) or syringe in all three axes of space. By empirically determining coordinates
using a stereotaxic atlas, and experimenter may locate and insert a cannula or
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syringe to a specific part of the brain without serious damage to the overlying
tissue. As can be seen from Table 1, the stereotaxic coordinates for this experiment
were empirically determined using the atlas of Paxinos and Watson (20).

Insert Table 1 about here

Apparatus and Behavioral Testing
In order to asses the retention of spatial learning in the rats, we tested them

on a partially baited 8-arm radial arm maze (RAM). The RAM consists of a center
platform about two and a half feet across with eight(six inch wide, two and a half
feet long) arms radiating from it. At the end of each arm there will be a white
painted plastic cup to hold reinforcement for the animals. Prior to actual testing,
all animals were given at least 5 days where the reinforcer (Froot Loops) was
liberally scattered on the RAM and the animal allowed to explore (habituation).
Following this phase, each subject was assigned to one of three maze orientations
and a random set of 5 arms which served as the baited set. This orientation
remained the same throughout the entire experiment. All behavioral testing was
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conducted blind (the experimenters did not know the condition of the rat). The
session began when the experimenter placed the subject on the center of the
platform. The animal was then allowed to choose among the arms until it either
successfully completed the test (obtains all 5 rewards) or until 10 minute had
elapsed. If the subject did not make a partial entry (approximately 2/3 of the way
down each arm is a piece of tape, if the subject crosses this line it will be
considered a partial entry) within the 'first 5 minutes the session was terminated.
The following parameters were reported at each session: the number of arms
revisited (total errors); correct errors, repeated entry into baited arms; incorrect
errors, repeated entry into non-baited arms; reference memory, entry into arms
that are never baited. Other behaviors of the subjects were also be reported such
as, urination and defecation. All scores were be summed and averaged over every

7 day block.
Results
The present study used an analysis of variance (ANOVA) test to qualitatively
examine the groups. Specifically, the ANOVA was a split plot mixed design with
blocks as the repeated measure and injection condition as the between group
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measure.

Multiple ANOVA's were performed on total errors, correct errors,

incorrect errors, reference memory errors and percent correct choice. Qualitative
examination of multiple injections of BA(1-42) + ibotenic acid reveal no significant
effects when compared to controls. Interestingly, the animals in all three groups
not only retained the learning from the pre-surgery task, but also improved by the
end of the

fou~th

block (Figures 1-5). All three groups had a higher percentage of

correct choices by the fourth block (Figure 1) and all error parameters that were
recorded were drastically reduced by the fourth block (Figures 2-5).

Insert Figures 1-5 about here

Discussion
The-results of the present study indicate that multiple injections of BA(1-42)
with a subthreshold dose of ibotenic acid does not significantly disrupt the retention
of a spatial learning task in male rats. In contrast to recent reports (7,29), this
study indicates that the neurotoxicity of BA may not reside in the amino acid
residues 1-42. Intriguingly, in the study done by Doman et al. (6) co-injections of
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BA(25-35)

+ rna did produce a deficit in a spatial learning task. It is interesting

to note, however, that Dornan eta!. assessed the effects of the BA injections on the
acquisition of spatial learning while the present study investigated the retention of
the task. The acquisition of learning is the initial learning done by the animals
while the retention of learning refers to what the animal has already learned.
In interpreting the data there are several factors to be considered. First of
all, the study lacked two control groups. Dimethylsulfoxide (DMSO) was used as
a vehicle for all of the conditions. Therefore, one group should have been injected
with DMSO alone to show that it has no neurotoxic effects by itself. The second
control group that should have been added was a group injected with scrambled
peptide. This would reveal any effect that a peptide, in general, would have on the
animal's behavior. Due to the high mortality rate resulting from multiple injections
(about 30%) and to the limited number of animals available, these control groups
were eliminated from the study.
Also related to the high mortality was the small statistical samples: Group
1, n=5; Group 2, n=4; Group 3, n=4. Small statistical samples may lead to
misinterpreted data. They can either magnify random trends or "hide" behavioral
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effects that may be significant.
At present histological examinations have not been performed. Histological
assessment can verify injection sites as well as provide information as to
hippocampal damage.

Therefore, the results of this study must be considered

preliminary and acknowledged with caution.
Finally,. evidence has suggested that the sensitivity of the radial arm maze to
measure the behavioral effects of hippocampal damage is controversial (2).
According to Neal Cohen (2), the hippocampal system plays a critical role in
mediating declarative memory.

Declarative memory is a memory system that

consists of a relational form of representation and has the property of flexibility.
For example, when a person finds their way from one point to another by using a
map, they are presumably using declarative memory.

In contrast, a form of

memory that operates independent of the hippocampal system, is procedural
memory (2).

Procedural memory supports a fundamentally inflexible form of

representation. For example, riding a bike or driving a car would be procedural
memory. If the radial arm maze task is used as a behavioral measure to assess
hippocampal damage, then its efficiency is determined by how well it can tap
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declarative memory.
While the rat is running the maze, it must learn to minimize the number of
arms that it enters due to the time constraint in which it is placed. Therefore, the
animal must identify arms that contain the reinforcer while keeping track of arms
that have already been visited. The rat may accomplish this by using spatial
representations of extraneous cues surrounding the maze. These abilities may be
dependent on declarative memory. It is'possible, however, that the animals develop
a "strategy" to complete the maze. They may enter one arm and then proceed to
complete the maze in systemic circular fashion. This type of strategy is related to
procedural memory. Therefore, if the animal runs the maze using a "strategy" it
may decrease the reliability of the radial arm maze to effectively measure the
behavioral effects of hippocampal damage.
While the results of the present study did not produce any significant results,
the extent of hippocampal damage that is required to elicit the behavioral effects of
BA is still unclear. Therefore, further investigation using multiple injections of
various sequences of BA may be required to better understand the role of BA in the
pathogenesis of AD. As others have suggested BA may be involved in promoting
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the vulnerability of otherwise heathy neurons to excitotoxic damage (3,6,10,16).
In contrast to the results of this study, BA may exert its neurotoxic effect of
hippocampal ne~rons indirectly via it Ca2+ dependent mechanism. In a recent
study done by Weiss, Pike and Cotman (29), the Ca2+ channel blocker,
nimodopine, attenuated BA toxicity (residues 1-40 and 1-42) to cortical neurons in
culture. They also reported that glutamate receptor antagonists, such as MK-801,
had no effect of BA neurotoxicity, This ,Suggests that voltage-sensitive Ca2 + channel
blockers may be required tet.attenuate BA injury. Therefore, further research on
BA may include ;investigating the behavioral effects of nimodopine following

injections of BA as well as the interaction of stress hormones on the BAPP induced
neurotoxicity.
These studies may allow for a better understanding of Alzheimer's disease
and the role of BA. Critical to this work, however, is the development of an animal
model of AD that mimics the profound impairment in memory characteristics found
in human AD patients. It is with this knowledge that new approaches to a treatment
for the disease will be possible.
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Table 1
Hippocampal Injection Coordinates

Direction

...-

Injection #

ML

AP

DV

1

4.6

2.3

3.3

2

4.6

3.3

3.3

3

5.2

4.6

5.0

4

5.2

4.6

5.5

Note.

The

table

sho'Ws

the

hippocampal

injection

coordinates

empirically determined using the atlas of Paxinos and Watson.

AP=

anterior poster-ior I ML= medial lateral and DV= dorsal ventral.

The

injections
injections.

were

bilateral

giving

each
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Figure Caption
Figure 1. Group differences in the mean percent correct choices over blocks 2-3
(1 block= 7 sessions).
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Figure Caption
Figure 2. Group differences in the mean number of correct errors committed over
the blocks (l block= 7 sessions). Correct errors are entry into arms that the rat
has already obtained food in the same session. Vertical lines indicate the standard
errors.
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Figure Caption
Figure 3. Group differences in the mean number of incorrect errors committed
over the blocks (1 block+ 7 sessions). Incorrect errors are repeated entry into
arms of the maze that are never baited. Vertical lines indicate the standard errors.
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Figure Caption
Figure 4. Group differences in the mean number of reference memory errors made
over the blocks (1 block+ 7 sessions). A reference memory error is an entry into
an arm of the maze that is never baited. Vertical lines indicate the standard errors.
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Figure Caption
Figure 5. Group differences in the mean number of total errors committed over the
blocks (1 block

+ 7 sessions).

Total errors include correct, incorrect and reference

memory errors. Vertical lines indicate the standard errors.
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